Background: A definitive treatment for functional dyspepsia (FD), and the role of Helicobacter pylori eradication on the course of this disease are controversial. Aim: To investigate the effect of a combination of acid-suppressing and prokinetic drugs or eradication therapy on the course of H. pylori-positive FD. Method: A total of 157 patients with endoscopically-proven H. pylori-positive FD and no response to 4 weeks of antacid therapy were randomly divided into 2 groups. 84 were placed on bismuth subnitrate plus metronidazole and amoxicillin (group A) and 73 received ranitidine and metoclopramide for 4 weeks (group B). The severity of symptoms (7 items) were assessed on a 6-point categorical scale. Group B patients who failed to respond to their medication underwent eradication therapy after 3 months. All patients were followed and assessed for 9 months after the end of therapy by the same clinicians who initiated the therapy. Results: At the end of the medication period, symptom’s score decreased significantly, and to the same extent. At 3-month follow-up moderate or complete response was achieved in 27.4% (group A) and 19.2% (group B) by intention-to-treat analysis. 34 patients of group B, not responding to treatment, underwent eradication therapy and followed as group A. Eradication of H. pylori was successful in 60 of 110 controlled patients (54%). After 9-month follow-up, complete or moderate response was observed in only 30% of 60 patients in whom H. pylori had been eradicated (intention-to-treat analysis), compared to 38% in 50 noneradicated cases (p > 0.05, 95% CI: 19–43 vs. 24–52). Conclusion: Eradication therapy with bismuth compound is effective as ranitidine plus metoclopramide in a subgroup of patients with FD not responding to antacid therapy. There is no difference in improvement between patients cured or not cured from H. pylori infection. This suggests that bismuth compounds were effective in FD when used in the eradication regimen. Combination therapy with acid-suppressing drugs plus prokinetic and bismuth seems to hold promise for FD.

1.
Veldhuyzen van Zanten SJO, Clearly C, Talley NJ, et al: Drug treatment of functional dyspepsia: Systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660–673.
[PubMed]
2.
Armstrong D: Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol 1996;31(suppl 215):38–47.
3.
Bernersen B, Johnsen R, Bostad L, et al: Is Helicobacter pylori the cause of dyspepsia? BMJ 1992;304:1276–1279.
[PubMed]
4.
Holtman G, Goebell H, Holtmann M, Talley NJ: Dyspepsia in healthy blood donors, pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994;39:1090–1098.
[PubMed]
5.
Agerus L, Engstrand L, Svaerd Sudd K, et al: Helicobacter pylori among Swedish adults with and without abdominal symptoms. Scand J Gastroenterol 1995;30:752–757.
[PubMed]
6.
Schilling D, Schauwecker P, Eberle F, et al: The pathogenic role of Helicobacter pylori infection in nonulcer dyspepsia: A cross-sectional evaluation of 6143 active employees in a large company (abstract). Gastroenterology 1998;114:279.
7.
Braden B, Caspary WF, Lembcke B: The density of gastric Helicobacter pylori colonization is not associated with the severity of symptoms in functional dyspepsia (abstract). Gastroenterology 1996;110:639.
[PubMed]
8.
Stone MA, Barnett DB, Mayberry JF: Lack of correlation between self-reported symptoms of dyspepsia and infection with Helicobacter pylori, in a general population sample. Eur J Gastroenterol Hepatol 1998;10:301–304.
[PubMed]
9.
Scott AM, Kellow JE, Shuter B, et al: Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Dig Dis Sci 1993;38:2247–2254.
[PubMed]
10.
Schlemper RJ, Van der Werf SD, Vanderbrouche JP, et al: Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori: Ulcer history as an explanation of an apparent association. Arch Intern Med 1995;155:82–87.
[PubMed]
11.
Schlemper RJ, Van der Werf SD, Biemond I, Lamers CB: Dyspepsia and Helicobacter pylori in Japanese employees with and without ulcer history. J Gastroenterol Hepatol 1995;10:633–638.
[PubMed]
12.
Wegener M, Borsch G, Schaffstein J, et al: Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying? Am J Gastroenterol 1988;83:737–740.
[PubMed]
13.
Pieramico O, Ditschuneit H, Malfertheiner P: Gastrointestinal motility in patients with non-ulcer dyspepsia: A role for Helicobacter pylori infection? Am J Gastroenterol 1993;88:364–368.
[PubMed]
14.
Minocha A, Mokshagundam S, Gallo SH, Rahal PS: Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol 1994;89:1797–1800.
[PubMed]
15.
Koskenpato J, Kairemo K, Korppi-Tomola T, Faerkkilae M: Role of gastric emptying in functional dyspepsia: A scintigraphic study of 94 subjects. Dig Dis Sci 1998;43:1154–1158.
[PubMed]
16.
Perri F, Clemente R, Festa V, et al: Pattern of symptoms in functional dyspepsia: Role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol 1998;93:2082–2088.
[PubMed]
17.
Laheij RJF, Jansen JBMJ, Van de Lisdonk EH, et al: Symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia (review article). Aliment Pharmacol Ther 1996;10:843–850.
[PubMed]
18.
Gilvarry J, Buclley MJM, Beattie S, et al: Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997;32:535–540.
[PubMed]
19.
Sheu BS, Lin CY, Lin ZX, et al: Long-term outcome of triple therapy in Helicobacter pylori-related non-ulcer dyspepsia: A prospective controlled assessment. Am J Gastroenterol 1996;91:441–447.
[PubMed]
20.
McColl K, Murray L, El-Omar E, et al: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869–1874.
[PubMed]
21.
Blum AL, Talley NJ, O’Morain, et al: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1875–1881
[PubMed]
22.
Talley NJ, Janssen J, Lauritzen K, et al: Eradication of Helicobacter pylori in functional dyspepsia: Randomized double blind placebo controlled trial with 12 months’ follow-up. BMJ 1999;318:837–841
[PubMed]
23.
Talley NJ, Vakil IV, Ballard ED, Fennerty MB: Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med 1999;341:1106–1111.
[PubMed]
24.
McColl KEL: Should we eradicate Helicobacter pylori in non-ulcer dyspepsia? Gut 2001;48:759–761.
[PubMed]
25.
Raju GS, Smith MJ, Morton D, Bardhan KD: Mini-dose (1 micro Ci) 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol 1994;89:1027–1031.
[PubMed]
26.
Saberi-Firoozi M, Massarrat S, Zare Z, et al: Effect of triple therapy of amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: A prospective, randomized, controlled study. Am J Gastroenterol 1995;90:1419–1423.
[PubMed]
27.
Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H: Peptic ulcer disease, irritable bowel syndrome and constipation. Eur J Gastroenterol Hepatol 1995;7:427–433.
[PubMed]
28.
Nyren O, Adami HO, Bates S, et al: Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986;314:339–343.
[PubMed]
29.
Soo S, Moayyedi P, Deeks J, Delaney B, Innes M, Forman D: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2000;CDOO 1960.
30.
Marshall BJ: The use of bismuth in gastroenterology. Am J Gastroenterol 1991;86:16–25.
[PubMed]
31.
Rokkas T, Pursey C, Uzoechina E, et al: Non-ulcer dyspepsia and short term De-Nol therapy: A placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1988;29:1386–1391.
[PubMed]
32.
Rosenstock S, Kay L, Rosenstock C, et al: Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 1997;41:169–176.
[PubMed]
33.
Matysiak-Budnik T, Poniewierka E, Gasciniak G, et al: 5 year follow-up study of chronic gastritis (abstract). Ir J Med Sci 1992;161(suppl 10):37.
34.
Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al: Systematic review and economic evaluation of H. pylori eradication for non ulcer dyspepsia. BMJ 2000;321:659–664.
[PubMed]
You do not currently have access to this content.